TEVA PHARMACEUTICALS, LTD. | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for TEVA PHARMACEUTICALS, LTD.

Sort by

Viewing results 1‒25 of 2747

News updates from April 30: Former Binance chief sentenced to prison; BlackRock to launch Saudi investment firm
FTC challenges ‘bogus’ pharma patents, including for Ozempic
...Patents affected by the FTC action also included weight-loss drugs produced by AstraZeneca, and asthma and COPD inhalers produced by GSK and Teva Pharmaceuticals....
April 30, 2024
LexPharmaceuticals sector
Why precision-guided chemotherapy has driven a dealmaking boom Premium content
...The money pouring into ADCs is a reminder of just how important oncology is to the pharmaceutical sector, even as obesity steals the limelight....
May 6, 2024
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
LexTeva Pharmaceutical Industries Ltd
Teva Pharma: generics titan attempts to put the stopper in legal problems Premium content
...The leader of the pack was Teva Pharmaceuticals, whose market capitalisation reached $60bn in 2015. Teva now sits in the crosshairs of law enforcement....
August 22, 2023
Deepmind Technologies Ltd
Google DeepMind unveils AI model for living cells
...Isomorphic Labs has partnerships with pharmaceutical companies Eli Lilly and Novartis....
May 8, 2024
Drug prices
Copycats take bite out of AbbVie’s best-selling Humira drug
...A Humira biosimilar from Teva Pharmaceuticals working with Alvotech earlier this year became the first drug that the US Food and Drug Administration granted interchangeable status, which lets pharmacists...
April 25, 2024
CVC Capital Partners Ltd
CVC agrees sale of troubled Africa tea estates business
...Browns is owned by Sri Lankan holding company LOLC Holdings, whose portfolio spans cars, pharmaceuticals, mining, agriculture and financial services....
May 7, 2024
FT Live
Funding Biopharma Innovation
Strategies for investing in drug development and commercialization
Wednesday, 26 June345 Park Avenue South, New York, NY, USA
News in-depthDementia
Alzheimer’s drug Leqembi falls short of blockbuster status in faltering US rollout
...“It was one of the most epic episodes ever in pharmaceuticals history: you got an accelerated approval of a product that didn’t have a completed phase 3 trial....
April 22, 2024
LexJonathan Guthrie
The Lex Newsletter: deus ex machina moments elevate tech and pharma Premium content
...Generics have been the métier of Teva rather than genetics. It is here that the story starts darkening....
August 25, 2023
Deepmind Technologies Ltd
DeepMind spin-off aims to halve drug discovery times following Big Pharma deals
...Instead, Isomorphic chose to sign deals with just two pharmaceutical companies....
January 10, 2024
Insider trading
A reality check on those Hamas insider trading claims
...And on closer look, those block trades weren’t quite as war-profiteering as they might sound: These are trades in SolarEdge Technologies and Teva Pharmaceuticals....
December 6, 2023
Coronavirus treatment
Expired Pfizer Covid antiviral drugs set to cost Europe $2.2bn, data shows
Millions of Paxlovid pills have gone unused as tight controls restrict access
January 1, 2024
LexFood & Beverage
Pepsi/obesity drugs: snack pack will withstand economies of scales Premium content
Investor worries about the impact of weight loss drugs on food companies are overdone
October 10, 2023
Genomics
Britain’s genetic databank to unveil largest-ever sequencing release
...The latest £200mn project was a collaboration funded by the government, Wellcome Trust, Britain’s biggest biomedical charity, and four pharmaceutical companies....
November 30, 2023
LexBoots UK Ltd
Boots: one step closer to the block Premium content
...The UK pharmaceutical retailer’s transfer of £4.8bn of pension obligations to insurer Legal & General brings its potential sale by owner Walgreens Boots Alliance one step closer....
November 24, 2023
Live news updates from November 22: Glazers mull Man Utd sale, Bankman-Fried ran FTX as ‘personal fiefdom’
Teva and Allergan agree $6.5bn opioids settlement
...Pharmaceutical groups Teva and Allergan have agreed to pay a combined $6.5bn to settle claims related to their role in fuelling the US opioids crisis....
November 22, 2022
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
LexDeepmind Technologies Ltd
Google DeepMind: drug developers seek a structural advantage from AI Premium content
Using AI should speed up detection of diseases caused by genetic variants but it does not guarantee success
September 19, 2023
LexPermira Holdings Ltd
Ergomed/Permira: buyout group sees drug trial group as contract thriller Premium content
Private equity group’s bid for researcher comes as the biomedical market is slowing down post-Covid
September 4, 2023
Artificial intelligence
DeepMind uses AI to predict harmful genetic mutations in humans
First example of artificial intelligence helping to accelerate diagnosis of diseases caused by genetic variants
September 19, 2023
Drugs research
New studies find benefits in very early drug treatment of Alzheimer’s
...But until recently, many large pharmaceutical companies were reluctant to invest heavily in finding treatments after decades of failure....
October 25, 2023
The Weekend Essay
Hauser & Wirth: the Swiss gallery that went global
...The virtue of putting private collections on public display is inculcated in Switzerland’s merchant class, the heirs to textile and pharmaceutical fortunes....
March 2, 2024
Disease control and prevention
Japanese drugmaker urges G7 to fix infectious diseases market
Shionogi chief warns companies are deserting the field to focus on more lucrative areas
August 28, 2023
Your QuestionsLucy Warwick-Ching
How can I stop my son investing his inheritance in crypto?
...In the second quarter of 2023 the FTSE All-Share pharmaceutical and biotechnology price return index closed 13 per cent higher than the FTSE All Share price return index....
September 20, 2023
Pharmaceuticals sector
Drugmaker warns US data rules threaten access to Alzheimer’s treatment
Japan’s Eisai says it will not finalise Leqembi spending plans until government clarifies financial support
June 17, 2023
Supply chains
US cancer drug shortage forces doctors to ration life-saving treatments
...The closure in April of a big US generics company Akorn Pharmaceuticals and Teva Pharmaceuticals’ decision last month to trim its generics portfolio highlight the extreme pressure the industry is under,...
June 4, 2023
Jayasree K Iyer
Poor countries desperately need better access to generic medicines
...Initially, the framework will be used to assess the efforts of five companies: Cipla, Hikma, Sun Pharma, Teva and Viatris....
February 15, 2023

Previous pagePage 1 of 110Next page